Sex and APOE ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer's disease
- PMID: 39711105
- PMCID: PMC11781133
- DOI: 10.1002/alz.14343
Sex and APOE ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer's disease
Abstract
Introduction: The effects of sex and apolipoprotein E (APOE)-Alzheimer's disease (AD) risk factors-on white matter microstructure are not well characterized.
Methods: Diffusion magnetic resonance imaging data from nine well-established longitudinal cohorts of aging were free water (FW)-corrected and harmonized. This dataset included 4741 participants (age = 73.06 ± 9.75) with 9671 imaging sessions over time. FW and FW-corrected fractional anisotropy (FAFWcorr) were used to assess differences in white matter microstructure by sex and APOE ε4 carrier status.
Results: Sex differences in FAFWcorr in projection tracts and APOE ε4 differences in FW limbic and occipital transcallosal tracts were most pronounced.
Discussion: There are prominent differences in white matter microstructure by sex and APOE ε4 carrier status. This work adds to our understanding of disparities in AD. Additional work to understand the etiology of these differences is warranted.
Highlights: Sex and apolipoprotein E (APOE) ε4 carrier status relate to white matter microstructural integrity. Females generally have lower free water-corrected fractional anisotropy compared to males. APOE ε4 carriers tended to have higher free water than non-carriers.
Keywords: Alzheimer's disease; aging; sex differences; white matter disease.
© 2024 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
S.C.J. has served on advisory boards for Enigma Biomedical and ALZPath in the past 2 years. A.J.S. receives support from multiple NIH grants (P30 AG010133, P30 AG072976, R01 AG019771, R01 AG057739, U19 AG024904, R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, U01 AG072177, U19 AG074879, and U24 AG074855). He has also received support from Avid Radiopharmaceuticals, a subsidiary of Eli Lilly (in kind contribution of PET tracer precursor) and participated in scientific advisory boards (Bayer Oncology, Eisai, Novo Nordisk, and Siemens Medical Solutions USA, Inc) and an observational study monitoring board (MESA, NIH NHLBI), as well as external advisory committees for multiple NIA grants. He also serves as editor in chief of
Figures



Update of
-
Sex, racial, and APOE-ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer's disease.bioRxiv [Preprint]. 2024 Jun 12:2024.06.10.598357. doi: 10.1101/2024.06.10.598357. bioRxiv. 2024. Update in: Alzheimers Dement. 2025 Jan;21(1):e14343. doi: 10.1002/alz.14343. PMID: 38915636 Free PMC article. Updated. Preprint.
Similar articles
-
White Matter Abnormalities and Cognition in Aging and Alzheimer Disease.JAMA Neurol. 2025 Aug;82(8):825-836. doi: 10.1001/jamaneurol.2025.1601. Epub 2025 Jun 9. JAMA Neurol. 2025. PMID: 40513084 Free PMC article.
-
Sex, racial, and APOE-ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer's disease.bioRxiv [Preprint]. 2024 Jun 12:2024.06.10.598357. doi: 10.1101/2024.06.10.598357. bioRxiv. 2024. Update in: Alzheimers Dement. 2025 Jan;21(1):e14343. doi: 10.1002/alz.14343. PMID: 38915636 Free PMC article. Updated. Preprint.
-
Associations between APOE-TOMM40 '523 haplotypes and limbic system white matter microstructure.Alzheimers Dement (Amst). 2025 Apr 6;17(2):e70099. doi: 10.1002/dad2.70099. eCollection 2025 Apr-Jun. Alzheimers Dement (Amst). 2025. PMID: 40201595 Free PMC article.
-
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S49-S63. doi: 10.1002/alz.13403. Epub 2023 Jul 26. Alzheimers Dement. 2023. PMID: 37496307 Free PMC article.
-
APOE ε4 and Dietary Patterns in Relation to Cognitive Function: An Umbrella Review of Systematic Reviews.Nutr Rev. 2025 Jul 1;83(7):e2113-e2126. doi: 10.1093/nutrit/nuae156. Nutr Rev. 2025. PMID: 39499795
Cited by
-
The effect of Alzheimer's disease genetic factors on limbic white matter microstructure.Alzheimers Dement. 2025 Apr;21(4):e70130. doi: 10.1002/alz.70130. Alzheimers Dement. 2025. PMID: 40219815 Free PMC article.
-
White Matter Abnormalities and Cognition in Aging and Alzheimer Disease.JAMA Neurol. 2025 Aug;82(8):825-836. doi: 10.1001/jamaneurol.2025.1601. Epub 2025 Jun 9. JAMA Neurol. 2025. PMID: 40513084 Free PMC article.
-
Longitudinal effects of sex differences and apolipoprotein E genotype on white matter engagement among elderly.Brain Commun. 2025 Jul 17;7(4):fcaf278. doi: 10.1093/braincomms/fcaf278. eCollection 2025. Brain Commun. 2025. PMID: 40740432 Free PMC article.
-
Cerebrospinal fluid YKL-40 relates to white matter hyperintensity progression in females but not males over a 6-year period.Alzheimers Dement (Amst). 2025 May 9;17(2):e70110. doi: 10.1002/dad2.70110. eCollection 2025 Apr-Jun. Alzheimers Dement (Amst). 2025. PMID: 40352684 Free PMC article.
-
Longitudinal tract-based spatial statistics analysis of white matter diffusivity changes and cognitive decline during the transition from MCI to Alzheimer's disease.PLoS One. 2025 Aug 5;20(8):e0329893. doi: 10.1371/journal.pone.0329893. eCollection 2025. PLoS One. 2025. PMID: 40763286 Free PMC article.
References
-
- Sachdev PS, Zhuang L, Braidy N, Wen W. Is Alzheimer's a disease of the white matter?. Curr Opin Psychiatry. 2013;26:244‐251. - PubMed
-
- Simpson JE, Ince PG, Higham CE, et al. Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol Appl Neurobiol. 2007;33:670‐683. - PubMed
MeSH terms
Substances
Grants and funding
- P30 AG066518/AG/NIA NIH HHS/United States
- P50 AG005142/AG/NIA NIH HHS/United States
- S10-OD02380 (Vanderbilt's High-Performance Computer Cluster for Biomedical Research)/GF/NIH HHS/United States
- P30 AG072959/AG/NIA NIH HHS/United States
- R01 AG015819/AG/NIA NIH HHS/United States
- P30 AG013854/AG/NIA NIH HHS/United States
- P30 AG053760/AG/NIA NIH HHS/United States
- P20 AG068082/AG/NIA NIH HHS/United States
- P30 AG072975/AG/NIA NIH HHS/United States
- R01 AG037639/AG/NIA NIH HHS/United States
- UH3 NS100599/NS/NINDS NIH HHS/United States
- P30 AG010124/AG/NIA NIH HHS/United States
- P50 AG023501/AG/NIA NIH HHS/United States
- UL1 TR000445/TR/NCATS NIH HHS/United States
- R01-EB017230/BAL
- UH2 NS100599/NS/NINDS NIH HHS/United States
- RF1 AG054047/AG/NIA NIH HHS/United States
- R01 AG056534/AG/NIA NIH HHS/United States
- P20 AG068053/AG/NIA NIH HHS/United States
- R01 EB017230/EB/NIBIB NIH HHS/United States
- P50 AG005131/AG/NIA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
- R01 AG067482/AG/NIA NIH HHS/United States
- U01 NS100599/NS/NINDS NIH HHS/United States
- P50 AG016574/AG/NIA NIH HHS/United States
- P50 AG005146/AG/NIA NIH HHS/United States
- U24 AG072122/AG/NIA NIH HHS/United States
- S10-OD023680/Vanderbilt's High-Performance Computer Cluster for Biomedical Research
- R01 AG073439/AG/NIA NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- P30 AG035982/AG/NIA NIH HHS/United States
- P50 AG008702/AG/NIA NIH HHS/United States
- R01 AG085571/AG/NIA NIH HHS/United States
- R01-AG034962 (ALJ)/GF/NIH HHS/United States
- K01-AG073584/DBA
- P01 AG003991/AG/NIA NIH HHS/United States
- P30 AG008051/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- K01 EB032898/EB/NIBIB NIH HHS/United States
- P01 AG026276/AG/NIA NIH HHS/United States
- R01 AG017917/AG/NIA NIH HHS/United States
- P50 AG047270/AG/NIA NIH HHS/United States
- P30 AG072980/AG/NIA NIH HHS/United States
- UL1-TR002243 (Vanderbilt Clinical Translational Science Award)/GF/NIH HHS/United States
- R01-AG059716 (TJH)/GF/NIH HHS/United States
- R01 AG062826/AG/NIA NIH HHS/United States
- U24 AG074855/AG/NIA NIH HHS/United States
- R01 AG054047/AG/NIA NIH HHS/United States
- P50 AG005136/AG/NIA NIH HHS/United States
- U24-AG074855 (TJH)/GF/NIH HHS/United States
- P30 AG049638/AG/NIA NIH HHS/United States
- P30 AG012300/AG/NIA NIH HHS/United States
- S10 OD021771/OD/NIH HHS/United States
- P50 AG016573/AG/NIA NIH HHS/United States
- UL1-TR002243/Vanderbilt Clinical Translational Science Award
- P50 AG047266/AG/NIA NIH HHS/United States
- R01 AG021155/AG/NIA NIH HHS/United States
- U24 AG041689/AG/NIA NIH HHS/United States
- R01-AG056534 (ALJ)/GF/NIH HHS/United States
- P50 AG005134/AG/NIA NIH HHS/United States
- P30 AG008017/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- U24-AG074855/TJH
- K01-EB032898 (KGS)/GF/NIH HHS/United States
- P50 AG025688/AG/NIA NIH HHS/United States
- R01 AG059716/AG/NIA NIH HHS/United States
- R01 AG064233/AG/NIA NIH HHS/United States
- R01-EB017230 (BAL)/GF/NIH HHS/United States
- UL1-TR000445 (Vanderbilt Clinical Translational Science Award)/GF/NIH HHS/United States
- P50 AG005133/AG/NIA NIH HHS/United States
- R01 AG080821/AG/NIA NIH HHS/United States
- R56 AG037639/AG/NIA NIH HHS/United States
- P20 AG068077/AG/NIA NIH HHS/United States
- S10 OD023680/OD/NIH HHS/United States
- P50 AG005138/AG/NIA NIH HHS/United States
- R01 AG022018/AG/NIA NIH HHS/United States
- R01-AG080821 (MH)/GF/NIH HHS/United States
- P30 AG066546/AG/NIA NIH HHS/United States
- U19-AG03655 (MA)/GF/NIH HHS/United States
- K01-AG073584 (DBA)/GF/NIH HHS/United States
- P50 HD103537/HD/NICHD NIH HHS/United States
- P50 AG047366/AG/NIA NIH HHS/United States
- R01 AG068193/AG/NIA NIH HHS/United States
- P20 AG068024/AG/NIA NIH HHS/United States
- P30 AG072958/AG/NIA NIH HHS/United States
- R01-AG062826 (KAG)/GF/NIH HHS/United States
- IIRG-08-88733(ALJ)/ALZ/Alzheimer's Association/United States
- R01-AG080821/Vanderbilt's High-Performance Computer Cluster for Biomedical Research
- P30 AG010129/AG/NIA NIH HHS/United States
- P30 AG019610/AG/NIA NIH HHS/United States
- UL1 TR002243/TR/NCATS NIH HHS/United States
- P30 AG072947/AG/NIA NIH HHS/United States
- R01 AG083865/AG/NIA NIH HHS/United States
- P50 AG033514/AG/NIA NIH HHS/United States
- R01 AG056405/AG/NIA NIH HHS/United States
- R01 AG034962/AG/NIA NIH HHS/United States
- 75N95D22P00141/ImNIH/Intramural NIH HHS/United States
- UL1-TR000445/Vanderbilt Clinical Translational Science Award
- K01 AG073584/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous